Adma Biologics (ADMA) Return on Sales [ROS] (2011 - 2026)
Adma Biologics (ADMA) recorded Return on Sales [ROS] of 48.02% in Q3 2026, up 10.01 percentage points from 38.01% a year earlier and up 5.86 percentage points from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
On a TTM basis, Adma Biologics' Return on Sales [ROS] came in at 46.47% as of Sep 30, 2026, up 12.28 percentage points year-over-year; for FY2025, it came in at 37.53%, up 4.93 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for five straight years, with a five-year change of +191.28 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at 32.59% in FY2024 (+24.21 pp), 8.38% in FY2023 (+33.93 pp), -25.55% in FY2022 (+46.57 pp) and -72.12% in FY2021 (+81.64 pp).
- Quarterly Return on Sales [ROS] has ranged from -50.91% in Q1 2022 to 50.90% in Q1 2026 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has increased for five consecutive quarters, with an average year-over-year change of +8.83 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 73.39 percentage points in Q4 2021, against a drop of 1.49 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 42.16% (Q2 2026), 50.90% (Q1 2026) and 45.09% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 32.98% |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 48.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 48.02% |
| Jun 30, 2026 | 42.16% |
| Mar 31, 2026 | 50.90% |
| Dec 31, 2025 | 45.09% |
| Sep 30, 2025 | 38.01% |
| Jun 30, 2025 | 35.08% |
| Mar 31, 2025 | 30.38% |
| Dec 31, 2024 | 32.60% |
| Sep 30, 2024 | 33.08% |
| Jun 30, 2024 | 36.57% |
| Mar 31, 2024 | 26.65% |
| Dec 31, 2023 | 19.26% |
| Sep 30, 2023 | 12.91% |
| Jun 30, 2023 | -0.79% |
| Mar 31, 2023 | -1.43% |
| Dec 31, 2022 | -12.12% |
| Sep 30, 2022 | -22.67% |
| Jun 30, 2022 | -27.06% |
| Mar 31, 2022 | -50.91% |
| Dec 31, 2021 | -50.00% |
API Access
Adma Biologics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();